What are TUDCA’s main benefits?
•Last Updated:
Last Updated:December 17, 2024
1.^Marciniak SJ, Chambers JE, Ron DPharmacological targeting of endoplasmic reticulum stress in disease.Nat Rev Drug Discov.(2022 Feb)
2.^Li J, Huang Z, Jin Y, Liang L, Li Y, Xu K, Zhou W, Li XNeuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review.Curr Neuropharmacol.(2024)
3.^Kim YH, Kim JH, Kim BG, Lee KL, Kim JW, Koh SJTauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling.J Gastroenterol Hepatol.(2019 Mar)
4.^Kusaczuk MTauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.Cells.(2019 Nov 20)
5.^Vang S, Longley K, Steer CJ, Low WCThe Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases.Glob Adv Health Med.(2014 May)
6.^Zangerolamo L, Vettorazzi JF, Rosa LRO, Carneiro EM, Barbosa HCLThe bile acid TUDCA and neurodegenerative disorders: An overview.Life Sci.(2021 May 1)
7.^Zucchi E, Musazzi UM, Fedele G, Martinelli I, Gianferrari G, Simonini C, Fini N, Ghezzi A, Caputo M, Sette E, Vacchiano V, Zinno L, Anceschi P, Canali E, Vinceti M, Ferro S, Mandrioli J, ERRALS study groupEffect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study.EClinicalMedicine.(2023 Nov)
8.^Elia AE, Lalli S, Monsurrò MR, Sagnelli A, Taiello AC, Reggiori B, La Bella V, Tedeschi G, Albanese ATauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis.Eur J Neurol.(2016 Jan)
9.^Ma H, Zeng M, Han Y, Yan H, Tang H, Sheng J, Hu H, Cheng L, Xie Q, Zhu Y, Chen G, Gao Z, Xie W, Wang J, Wu S, Wang G, Miao X, Fu X, Duan L, Xu J, Wei L, Shi G, Chen C, Chen M, Ning Q, Yao C, Jia JA multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis.Medicine (Baltimore).(2016 Nov)
10.^Larghi A, Crosignani A, Battezzati PM, De Valle G, Allocca M, Invernizzi P, Zuin M, Podda MUrsodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study.Aliment Pharmacol Ther.(1997 Apr)
11.^Crosignani A, Battezzati PM, Setchell KD, Invernizzi P, Covini G, Zuin M, Podda MTauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study.Dig Dis Sci.(1996 Apr)
12.^Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, Patterson BW, Horton JD, Mittendorfer B, Hotamisligil GS, Klein STauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.Diabetes.(2010 Aug)
13.^Walsh LK, Restaino RM, Neuringer M, Manrique C, Padilla JAdministration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.Clin Sci (Lond).(2016 Nov 1)
14.^Häussinger D, Kordes CMechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection.Dig Dis.(2017)
15.^Duan WM, Rodrigures CMP, Zhao LR, Steer CJ, Low WCTauroursodeoxycholic Acid Improves the Survival and Function of Nigral Transplants in a Rat Model of Parkinson's Disease.Cell Transplant.(2002 Apr)
16.^Wimmer R, Hohenester S, Pusl T, Denk GU, Rust C, Beuers UTauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.Gut.(2008 Oct)
17.^Sommerfeld A, Reinehr R, Häussinger DTauroursodeoxycholate Protects Rat Hepatocytes from Bile Acid-Induced Apoptosis via β1-Integrin- and Protein Kinase A-Dependent Mechanisms.Cell Physiol Biochem.(2015)
18.^Chen X, Wang J, Gao X, Wu Y, Gu G, Shi M, Chai Y, Yue S, Zhang JTauroursodeoxycholic acid prevents ER stress-induced apoptosis and improves cerebral and vascular function in mice subjected to subarachnoid hemorrhage.Brain Res.(2020 Jan 15)
19.^Zhang X, Shahani U, Reilly J, Shu XDisease mechanisms and neuroprotection by tauroursodeoxycholic acid in Rpgr knockout mice.J Cell Physiol.(2019 Aug)
20.^Xu X, Wang M, Li JZ, Wei SD, Wu H, Lai X, Cao D, Ou ZB, Gong JTauroursodeoxycholic acid alleviates hepatic ischemia reperfusion injury by suppressing the function of Kupffer cells in mice.Biomed Pharmacother.(2018 Oct)
21.^Drack AV, Dumitrescu AV, Bhattarai S, Gratie D, Stone EM, Mullins R, Sheffield VCTUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice.Invest Ophthalmol Vis Sci.(2012 Jan 5)
22.^Cho EJ, Yoon JH, Kwak MS, Jang ES, Lee JH, Yu SJ, Kim YJ, Kim CY, Lee HSTauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet.Dig Dis Sci.(2014 Jul)
23.^Wang W, Zhao J, Gui W, Sun D, Dai H, Xiao L, Chu H, Du F, Zhu Q, Schnabl B, Huang K, Yang L, Hou XTauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.Br J Pharmacol.(2018 Feb)
24.^Lawson EC, Bhatia SK, Han MK, Aung MH, Ciavatta V, Boatright JH, Pardue MTTauroursodeoxycholic Acid Protects Retinal Function and Structure in rd1 Mice.Adv Exp Med Biol.(2016)
25.^Cuevas E, Burks S, Raymick J, Robinson B, Gómez-Crisóstomo NP, Escudero-Lourdes C, Lopez AGG, Chigurupati S, Hanig J, Ferguson SA, Sarkar STauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease.Nutr Neurosci.(2022 Jul)
26.^Fu J, Aung MH, Prunty MC, Hanif AM, Hutson LM, Boatright JH, Pardue MTTauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes.Pharmaceutics.(2021 Jul 27)